Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS

作者: Ruben J. Boado , William M. Pardridge

DOI:

关键词: Blood–brain barrierIduronate-2-sulfatase activitySystemic administrationChemistryAntibodyImmunology

摘要: Provided herein are methods and compositions for treating a subject suffering from deficiency in iduronate 2-sulfatase the CNS. The include systemic administration of bifunctional fusion antibody comprising an that crosses blood brain barrier (BBB) 2-sulfatase.

参考文章(384)
Wolf-R. Schäbitz, Stefan Schwab, Matthias Spranger, Werner Hacke, Intraventricular Brain-Derived Neurotrophic Factor Reduces Infarct Size after Focal Cerebral Ischemia in Rats: Journal of Cerebral Blood Flow and Metabolism. ,vol. 17, pp. 500- 506 ,(1997) , 10.1097/00004647-199705000-00003
J. E. Wraith, Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties. Journal of Inherited Metabolic Disease. ,vol. 24, pp. 245- 250 ,(2001) , 10.1023/A:1010379320378
W A Jefferies, S V Hunt, A F Williams, M R Brandon, Analysis of lymphopoietic stem cells with a monoclonal antibody to the rat transferrin receptor. Immunology. ,vol. 54, pp. 333- 341 ,(1985)
Caryn Bowe, Robert Bayer, David Hakes, Shawn DeFrees, Xi Chen, David Zopf, Alpha galalctosidase a: remodeling and glycoconjugation of alpha galactosidase A ,(2003)